First drug to delay onset of type 1 diabetes made available on NHS (opens original article in a new tab)

The NHS in England and Wales has started offering teplizumab, the first drug to delay the onset of type 1 diabetes, providing patients with three extra years before needing insulin treatment. The drug, an immunotherapy, is described as 'genuinely exciting' by the NHS medicines body, with potential benefits for hundreds of children each year. The treatment involves a 14-day infusion and is available for those showing early signs of the disease.

• NHS in England and Wales starts offering teplizumab, the first drug to delay type 1 diabetes onset.
• Teplizumab provides three extra years before insulin treatment is needed through immunotherapy.
• NHS medicines body calls decision 'genuinely exciting' with potential benefits for hundreds of children annually.